Completed PHASE3 INTERVENTIONAL 3-arm NCT01143025

Intraperitoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Surgery

Peritoneal Nebulization of Ropivacaine for Postoperative Pain Control After Laparoscopic Cholecystectomy

Sponsor: Azienda L'ULSS 15 Alta Padovana

Interventions Ropivacaine 100 mg Ropivacaine 150 mg Ropivacaine 50 mg

Updated 5 times since 2017 Last updated: May 18, 2011 Started: Mar 31, 2010 Primary completion: Apr 30, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Laparoscopic Cholecystectomy, this trial is completed. The trial is conducted by Azienda L'ULSS 15 Alta Padovana and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda L'ULSS 15 Alta Padovana
Azienda U.S.L. della Valle d'Aosta, Ospedale Regionale Umberto Parini
Fondazione IRCCS Policlinico San Matteo di Pavia
Gruppo Ospedaliero San Donato, Policlinico San Pietro, Ponte San Pietro, Bergamo
San Gerardo Hospital
University of Milano Bicocca

Data source: San Gerardo Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Monza, Italy